The Zhitong Finance App learned that Yun Zhisheng (09678) rose more than 7%. As of press release, it had risen 6.91% to HK$52.75, with a turnover of HK$18.523,300.
According to the news, according to Yunzhisheng's official WeChat account, Yunzhisheng recently reached a fund supervision system project cooperation with a leading financial insurance group. The two sides will rely on YunZhisheng's self-developed U2-Med Three Medical University models, intelligent audit algorithms, and medical insurance business knowledge to jointly build an integrated intelligent supervision plan covering pre-warning, in-event monitoring, and post-factual traceability. Previously, Yun Zhisheng won the bid for the Financial Insurance Group's Health Insurance Fund Supervisory Agent and Health Insurance Knowledge Intelligent Question and Answer Agent, and continues to explore the application of smart technology in health insurance supervision and public service scenarios.
According to reports, Yunzhisheng's three-medical university model U2-Med is based on a self-developed U2-Flash base model, integrates expertise in the medical, medical insurance (including commercial insurance), and pharmaceutical fields, can understand professional content such as medical records, examination reports, prescription documents, policy terms, etc., and carries out information extraction, correlation analysis and auxiliary reasoning to provide technical support for medical insurance reviews and commercial insurance claims. In the two medical dialogue ability assessments, HealthBench Full and HealthBench Hard, launched by OpenAI, U2-Med scored 73.67 points and 61.07 points respectively, ranking first among the participating models.